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Abstract 
Purpose: To investigate the anti-thrombosis and anti-tumor effect of the water extract of the caulis of 
Sargentodoxa cuneata (Oliv.) Rehd. et Wils. (WCSW) in rat and mouse models. 
Methods: WCSW extract was prepared and the main constituents were determined by high pressure 
liquid chromatography (HPLC). The acute toxicity of the extract was determined in mice. Platelet 
aggregation in rat platelet-rich plasma (PRP) was examined to evaluate the effect of the extract on 
platelet function. Thereafter, the cytotoxic activity of WCSW on HL60, A549, S180 and H22 cells was 
determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. In vivo anti-
tumor effect of WCSW was further evaluated on H22 cells transplanted in mice, while the expression of 
caspase-3, caspase-9, Bcl-2 and Bax proteins were assayed by Western blot analysis.  
Results: Protocatechuic acid, rhodiola glucoside and chlorogenic acid were identified as the main 
constituents of WCSW. Platelet aggregation was significantly inhibited by treatment with the extract at 
concentrations of 1, 5 and 10 mg/mL. WCSW also showed significant inhibitory effect on HL60, A549, 
S180 and H22 cells in vitro with half maximal inhibitory concentration (IC50 value of 321.9, 285.0, 130.3 
and 76.1 μg/mL, respectively. Furthermore, WCSW exhibited obvious anti-tumor effect on H22 
transplanted tumor in vivo. After treatment with WCSW, caspase-3, caspase-9 and Bax were 
significantly (p < 0.05) up-regulated, whereas Bcl-2 was significantly (p < 0.05) down-regulated in the 
tumor tissues.   
Conclusion: WCSW possesses significant antithrombosis and anti-tumor effect, and therefore, has the 
potentials to be developed into effective drugs for clinical treatment of cancer and thrombosis diseases. 
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Thrombus formation is a pivotal event involved in 
the pathogenesis of cardiovascular disease, and 
platelets are critical in all phases of thrombus 
formation [1]. Antithrombotic drugs, such as 
adenosine diphosphate (ADP) receptor blockers, 
acetylsalicylic acid (aspirin), and glycoprotein 
(GP) IIb/IIIa antagonists are used to prevent 
cardiovascular disease [2]. However, these drugs 
can have systemic hemorrhagic side effects 
[3,4]. Cancer is a very serious medical condition 
worldwide. The current medical treatments for 
cancer including chemotherapy and 
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radiotherapy, often have serious side effects 
[5,6]. Therefore, it is very important to develop 
much safer antithrombotic and anti-tumor agents 
with fewer side effects. 
 
Sargentodoxa cuneata (Oliv.) Rehd. et Wils. 
(SRW), belonging to Lardizabalaceae, is a 
common Chinese medicinal plant which is 
distributed in South, East, Central and Southwest 
China [7]. The caulis of SRW is used in China for 
treating acute appendicitis, abdominal pain, 
rheumatic arthritis, trauma, amenorrhea and 
dysmenorrhea [8]. Several kinds of compounds 
such as lignans, triterpenes, anthraquinones, 
phenolic acids, and phenylpropanoids have been 
previously isolated from SRW [7,9]. However, to 
the best of our knowledge, only a few researches 
reported the pharmacological activities of SRW. 
The present research was aimed to investigate 
the antithrombosis and anti-tumor effect of water 
extract of caulis of SRW (WCSW), which may 
encourage the development and application of 




Chemicals and reagents 
 
Adenosine 5’-diphosphate (ADP), collagen, 
acetylsalicylic acid (AA) and 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) were purchased from Sigma (St. 
Louis, MO, USA). Protocatechuic acid, Rhodiola 
glucoside, and Chlorogenic acid standards were 
purchased from National Institute for Food and 
Drug Control (Beijing, China). 5-Fluorouracil (5-
FU) was obtained from Sinopharm Chemical 
Reagent Co., Ltd. (Shanghai, China). Caspase-3, 
caspase-9, Bcl-2, Bax, and β-actin antibodies 
were purchased from Beyotime Institute of 
Biotechnology (Nanjin, China). All the other 
chemicals used were of analytical grade.  
 
Preparation of WCSW 
 
Dried crude caulis of SRW was purchased from 
Chengdu Hehuachi Chinese Herbal Medicine 
Market (Chengdu, China) in August, 2015, and 
identified by the Oncology Department of 
Traditional Chinese Medicine (Chongqing Cancer 
Research Institute，Chongqing, China). A 
voucher specimen (no. HM2015-0807) was 
deposited in the laboratory herbarium of 
Chongqing Cancer Research Institute. The caulis 
of SRW was powdered and refluxed two times 
for 2 h each time with distilled water. The filtrates 
were concentrated under reduced pressure at 40 
°C and the final yield of the extract (WCSW) was 
about 12.7 % (w/w). 
 
Determination of major constituents of 
WCSW  
 
An HPLC system consisting of Waters 2695 
HPLC and UV detector (Waters, USA) was used 
to analyze the constituents in WCSW. The 
components of WCSW were isolated on a 
Diamonsil C18 (250 × 4.6 mm, with 5 μm particle 
size) column (Dikma, Beijing). The column 
temperature was controlled at 30 °C and the UV 
detector was set at 280 nm. The gradient elution 
system was composed of acetonitrile as solvent 
A and 0.05 % solution of phosphoric acid in 
water as solvent B, and was set as follows: 0-10 
min, 95 % B; 10 - 35 min, 95 % - 84% B; 35 - 50 
min, 84 % - 75 % B; 50 - 60 min, 75 % - 55 % B. 




ICR mice (20 ± 2 g) and Sprague-Dawley (SD) 
rats (210 ± 10 g) were purchased from Dashuo 
experimental animal Co. Ltd. (Chengdu, China). 
Animals were maintained at 23 ± 2 °C and 55 ± 5 
% humidity under a 12-h light/12-h dark cycle 
and free access to food and water. All the animal 
treatments were strictly in accordance with 
Directive 2010/63/EU on the Handling of Animals 
Used for Scientific Purposes [10]. The 
experimental procedures were approved by the 
Animal Care and Use Committee of Chongqing 
Cancer Research Institute (approval no. 201509-
N-12). 
 
Cell culture  
 
The cell lines of A549, HL60, S180 and H22 
were cultured in RPMI medium supplemented 
with 10 % fetal bovine serum and antibiotics (100 
U/mL penicillin and 100 μg/mL streptomycin), 
and incubated at 37 °C in the presence of 5 % 
CO2. 
 
Acute toxicity test 
 
Acute toxicity of WCSW on mice was carried out 
according to a previous report [11]. Mice were 
divided into six groups (n=10) and fasted for 12 h 
prior to the experiment with free access to water. 
The animals were administered orally with a 
single dose of WCSW (10, 100, 500, 1000 and 
2000 mg/kg), or distilled water for the control 
group. After that, the mice were observed for 
clinical signs and mortality at 0.5, 1, 2, 4, and 6 h 
after dosing and twice a day thereafter for 14 
days. 
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Assessment of platelet aggregation 
 
Platelet aggregation was determined using the 
turbidimetric method reported by Xin et al [12]. 
SD rats were lightly anesthetized with diethyl 
ether. Blood was drawn from the abdominal aorta 
and collected into blood collection tube 
containing 3.8 % sodium citrate (1:9, v/v). 
Platelet-rich plasma (PRP) was prepared by 
centrifuged at 800 rpm for 10 min. Platelet-poor 
plasma (PPP) was obtained by further 
centrifuged at 3000 rpm for 10 min. The PRP 
was diluted with PPP to make platelet 
concentration of 5 ×108 /mL.  
 
For the aggregation experiment, the diluted PRP 
was incubated at 37 °C for 5 min with different 
concentrations of WCSW (1, 5 and 10 mg/mL). 
Subsequently, arachidonic acid (0.5 mmol/L), 
ADP (5 μmol/L), or collagen (3.2 μg/mL) was 
added to induce platelet aggregation. Aspirin (25 
μg/mL) was used as positive control. The 
changes in light transmission were recorded for 5 
min.  
 
MTT assay  
 
Cells were seeded into 96-well plates at a 
concentration of 1 × 105/ 0.1 mL in the presence 
of WCSW (10 - 640 μg/mL) for 48 h. The growth 
inhibitory effect of the cells was determined by 
MTT assay. Briefly, each well was added 20 μL 
MTT (5 mg/mL) and incubated for another 4 h. 
Then the culture medium was removed, and 150 
μL DMSO was added to each well. Absorbance 
was detected by a microplate reader at 570 nm. 
Inhibition (I) of cell proliferation was calculated by 
Eq 1. 
 
I (%) = {(Ac- At)/Ac}100 ……………………. (1) 
 
where Ac and At are the absorbance of control 
and treatment samples respectively. 
 
In vivo antitumor experiment  
 
H22 tumor cell suspension (2 × 106 cells/mouse, 
0.2 mL) was subcutaneously injected into the 
right armpits of ICR mice to establish the animal 
model [13]. The mice were randomly divided into 
five groups (n = 10): the model control group, the 
positive group and three WCSW-treated groups 
(20, 40 and 80 mg/kg) by intragastric 
administration (ig). Control group was treated 
with normal saline {20 mL/kg, intraperitoneally 
(ip)} while the positive group was treated with 5-
FU (20 mg/kg, ip). All the mice were sacrificed 
after treatment for 14 days, and the whole bodies 
and the segregated tumor of the mice were 
weighed immediately. 
 
Western blot analysis 
 
Total proteins were extracted from the tumor 
tissues. Protein samples (50 μg) were separated 
using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS/PAGE). Thereafter, the 
separated proteins were transferred to a 
polyvinylidene difluoride (PVDF) membrane and 
probed with different primary antibodies targeting 
caspase-3, caspase-9, Bax, or Bcl-2 overnight at 
4 °C. After washing with Tris buffered saline 
three times, the membrane was incubated with 
secondary antibodies. The proteins were 
detected using chemiluminescence peroxidase 
reagents. Antibody directed against β-actin was 




Data are expressed as mean ± standard 
deviation (SD). One-way ANOVA followed by t-
test was performed on the data using SPSS 
software (SPSS for Windows 18.0, SPSS Inc, 
USA) to determine differences between the 
treated and control groups. P < 0.05 was 




Main constituents of WCSW  
 
In order to detect the constituents in WCSW, 
HPLC was performed in the present study. As 
shown in Figure 1, WCSW was well separated 
under the experimental conditions. Three 
constituents including protocatechuic acid, 
rhodiola glucoside and chlorogenic acid were 
identified by comparing their retention times and 
UV spectra with the corresponding reference 
standards. 
 
Acute toxicity  
 
Acute toxicity of WCSW was carried out in mice 
by oral administration. As a result, there was no 
death and significant modification in the general 
behavior of the animals after 14 days at all the 
administered doses of WCSW. Hence, WCSW 
was apparently safe when administered orally to 
mice under the studied doses. 
 
Effect of WCSW on platelet aggregation in 
vitro 
 
The effect on ADP, AA and collagen induced 
platelet aggregation in rat PRP were examined to 
evaluate the effect of WCSW on platelet function. 
Platelet aggregations induced by collagen and  
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Figure 1: HPLC chromatogram for WCSW. (1) protocatechuic acid, (2) rhodiola glucoside, (3) chlorogenic acid 
 
 
Figure 2: The effect of WCSW on platelet aggregation. *p < 0.05 compared with the control group. **p < 0.01 
compared with control group 
 
AA were significantly inhibited by treating with 
WCSW at the concentrations of 1, 5, and 10 
mg/mL (p < 0.05, p < 0.05 and p < 0.01, 
respectively) in a concentration-dependent 
manner (Figure 2). Furthermore, the inhibitory 
effect of WCSW on the platelet aggregations 
induced by ADP was also significant at the 
concentrations of 5 and 10 mg/mL (p < 0.05 and 
p < 0.01, respectively). 
 
Cytotoxic activity of WCSW in vitro 
 
The proliferation of HL60, A549, S180 and H22 
cells was determined to investigate the cytotoxic 
activities of WCSW and the cell viability was 
determined by the MTT assay. The results in 
Figure 3 indicate WCSW exerted significant 
inhibitory effects on HL60, A549, S180 and H22 
cells (the IC50 values were 321.9, 285.0, 130.3, 
and 76.1 μg/mL, respectively) in a concentration-
dependent manner. Thus, H22 cells were the 
most sensitive in responding to WCSW 
administration. 
 
Effect of WCSW on H22 transplanted tumor in 
vivo 
 
Anti-tumor activity of WCSW in H22 cell 
transplanted mice was evaluated based on its 
favorable in vitro cytotoxic activity against hepatic 
carcinoma cells. As shown in Figure 4, the 
average tumor weight of the mice in WCSW  
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Figure 4: Anti-tumor effect of WCSW on H22 transplanted tumor in vivo. *p < 0.05 compared with the control 
group; **p < 0.01 compared with control group. 
 
 
Figure 5: Effect of WCSW on expressions of apoptosis-related proteins caspase-3, caspase-9, Bcl-2 and Bax 
 
treated groups (40 and 80 mg/kg) were 
significantly lower than that of the control group, 
indicating that WCSW had anti-tumor effect on 
H22 transplanted tumor in vivo.  
 
WCSW induced cell apoptosis in H22 
transplanted tumor 
 
To determine whether WCSW treatment induced 
cell apoptosis in transplanted tumors, the protein 
expressions of caspase-3, caspase-9, Bcl-2 and 
Bax were assayed by western blot analysis. β-
actin was used as internal control to ensure that 
equal amount of proteins were loaded in each 
lane. From the results in Figure 5, the 
expressions of caspase-3, caspase-9 and Bax 
proteins were significantly up-regulated, whereas 
the expression Bcl-2 was significantly down-
regulated in the tumor tissues of the mice treated 
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with WCSW at the doses of 20, 40 and 80 mg/kg 




It was reported that activation and aggregation of 
platelets play important roles in thrombotic 
complications, such as myocardial infarction, 
acute coronary syndromes and atherosclerosis, 
etc. [14,15]. Recently, there has been increasing 
interest to isolate thrombolytic and anti-
thrombotic agents from food and natural sources, 
which are presumed to be effective and safe [16]. 
In the present study, the antithrombosis effect of 
WCSW were studied, and it was proved to be 
safe by oral administration and possessed 
significant inhibitory effect on ADP, AA and 
collagen induced platelet aggregation in rat PRP. 
Caspases are the key proteins that regulate 
apoptotic response, and the activation of 
caspase-3 and caspase-9 is one of the most 
common involvements in the process of 
apoptosis in many cell types [17,18]. The 
mitochondrial pathway of apoptosis is regulated 
by the Bcl-2 family, and Bcl-2 and Bax are the 
two major members of Bcl-2 family [19]. The 
increase in the ratio of Bax/Bcl-2 is beneficial to 
apoptosis [20]. Furthermore, it is well known that 
the caspase family plays a vital role in cells 
undergoing apoptosis by interfering with the Bcl-
2 family [21]. Thus, the expressions of caspase-
3, caspase-9, Bcl-2 and Bax proteins were 
evaluated in the present study. The results 
indicated that WCSW induced apoptosis in H22 
tumor by shifting the Bax/Bcl-2 ratio and 
increasing the caspase-9 and caspase-3 
activation. 
 
In addition, more investigations should be carried 
out in the future to explore the constituents 
regarding the antithrombotic and anti-tumor 




The findings of the present study indicate that 
WCSW possesses significant antithrombotic 
effect by inhibiting platelet aggregation. The 
extract also exerts significant anti-tumor effect by 
inducing apoptosis. Thus, WCSW has potentials 
to be developed into and effective drug for the 
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